Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4026083 | Ophthalmology | 2014 | 7 Pages |
Abstract
In this study, tocilizumab was effective in the treatment of refractory inflammatory ME. No serious adverse events were observed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Marina MD, Blanca PhD, Victor MD, PhD, Maite MD, PhD, Alfredo MD, PhD,